Latest news
Vectus Biosystems Appoints Dr Tara Speranza as CEO and CTO, Raises $791,000 to Accelerate VB0004 Clinical Development - KalkineKalkine · Tue, 28 Jul 2026 07:00:00 GMTVectus Biosystems Names Dr Tara Speranza as CEO and CTO, Secures $791K to Boost VB0004 Phase Ib Trials - Kalkine MediaKalkine Media · Tue, 28 Jul 2026 07:00:00 GMT